Building Expertise in Cell Therapy: Insights from the CliniMACS Prodigy© Workshop

Last week, our CliniMACS Prodigy© workshop brought together a diverse group of researchers, biotech manufacturing experts and graduate students specialising in cell therapy research, stem cell biology and GMP cell manufacturing for an insightful exchange.

Jointly organised with Miltenyi Biotec, the workshop offered participants hands-on learning and a deep dive into the Adherent Cell Culture (ACC) process to learn how such systems enable the culture and expansion of stem cells in a GMP-compliant setting.

Likening the programming of manufacturing processes to the assembly of Lego blocks, Dr Kelly Wee, PhD and Dr Shu Cheng W., Technical and Application, Miltenyi Biotec, shed light on the benefits of consistent and scalable GMP-compliant manufacturing. It was an insightful afternoon where participants explored the system and customised sample modular applications.

Through these training initiatives, ACTRIS aims to equip the local cell therapy manufacturing workforce with the skills and knowledge required to effectively utilise new technologies, paving the way for greater innovation applications in targeted therapeutic interventions and improving patient outcomes. We hope to cultivate a community of knowledge experts in cell and gene therapy.

You may view our LinkedIn post here.